Q2 2026 Rede D'Or Sao Luiz SA Earnings Call (English, Portuguese) Transcript
Key Points
- Hospital services EBITDA margin expanded to 26.6% in Q2 2026, up 2.3 percentage points year-on-year, driven by operational efficiency and cost control.
- Oncology segment showed robust growth, with gross revenue up 22.3% year-on-year, reflecting strong volume growth of 15.2%.
- SulAmérica's consolidated loss ratio improved by 3.2 percentage points year-on-year to 78.1%, indicating better cost management and portfolio quality.
- Adjusted EBITDA for SulAmérica grew 53.2% year-on-year, contributing to a consolidated adjusted EBITDA growth of 23.6%.
- The company maintains a strong balance sheet with net debt-to-EBITDA of 1.71x (or 1.1x when including technical provisions), no financial covenants, and a solid cash position of BRL47.9 billion.
- Operational efficiency initiatives, including procurement and technology, are yielding results, with cost growth (6.5%) outpaced by revenue growth (9.9%) in hospital services.
- SulAmérica added 40,000 lives in Q2 2026, a significant improvement from 17,000 in Q1, indicating accelerating growth in the health plan portfolio.
- The company continues to expand its hospital network, adding 183 beds year-on-year, with a focus on high-occupancy regions like São Paulo, Rio, and Brasília.
- Rede D'Or received recognition as one of the most sustainable hospital networks globally, with 29 hospitals ranked among the top 250 sustainable hospitals by Newsweek.
- The company's long-term growth trajectory is strong, with revenue and adjusted EBITDA growing from BRL50-60 billion and BRL3.2 billion to BRL12.7 billion, respectively, over the past 5.5 years.
- Hospital occupancy declined year-on-year due to seasonality and the discontinuation of contracts with certain operators, impacting patient days.
- The company had to discontinue contracts with some self-managed operators, particularly in the Northeast, which negatively affected volume and required adjustments in specific hospitals.
- General and administrative expenses grew 23.1% year-on-year in Q2 2026, though adjusted growth was 12%, still above revenue growth in some periods.
- SulAmérica's loss ratio worsened by 29% quarter-on-quarter due to seasonality, though it improved year-on-year.
- The company faces challenges from judicialization in the health sector, leading to increased litigation and contingency reviews.
- Net income growth was impacted by one-off positive items in Q2 2025, making year-on-year comparisons less favorable; adjusted net income grew 17.9%.
- The company's exposure to interest rate and monetary shocks is a concern, though mitigated by technical provisions and cash position.
- Working capital variation was negative in the first half of 2026, with a consumption of BRL340 million in the hospital segment, though SulAmérica contributed positively.
- The company's capital allocation strategy is cautious, with fewer M&A opportunities in the last two years, potentially limiting inorganic growth.
- The average ticket growth in hospital services (9.9% year-on-year) is partly driven by mix shifts toward more complex procedures, which may not be sustainable if the mix normalizes.
Good morning, everyone. Welcome to the earnings call of the second quarter of 2026 of Rede D'Or. . We are here today with us Mr. Paulo Moll, President; Rodrigo Gavina, CEO of Hospitals; Otavio Lazcano, VP of Finance and IR; and Raquel Reis, CEO of Healthcare and Dental of SulAmérica.
This event should take about one hour and the recording will be available at the IR website. (Operator Instructions) Before we should continue, we would like to clarify that any forward-looking statements that are done during the earnings call regarding the business perspectives of Rede D'Or projections and operational goals, financial goals are based on beliefs and premises of the Board of Directors based on information that is currently available.
Forward-looking statements are not a guarantee of performance, and they involve risks and uncertainties. They refer to things that may occur or not. General economic conditions, industry conditions and other operational factors may affect the performance of the company and may lead to results that are materially different from those expressed in the forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
